T. Rowe Price Investment Management, Inc. Exact Sciences Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $166 Billion
- Q3 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Exact Sciences Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 3,392,838 shares of EXAS stock, worth $204 Million. This represents 0.14% of its overall portfolio holdings.
Number of Shares
3,392,838
Previous 2,941,202
15.36%
Holding current value
$204 Million
Previous $124 Million
85.99%
% of portfolio
0.14%
Previous 0.08%
Shares
9 transactions
Others Institutions Holding EXAS
# of Institutions
672Shares Held
163MCall Options Held
2.58MPut Options Held
2.19M-
Vanguard Group Inc Valley Forge, PA17.8MShares$1.07 Billion0.02% of portfolio
-
Capital World Investors Los Angeles, CA15.8MShares$952 Million0.17% of portfolio
-
Wellington Management Group LLP Boston, MA14.3MShares$861 Million0.18% of portfolio
-
Black Rock Inc. New York, NY12.1MShares$725 Million0.01% of portfolio
-
State Street Corp Boston, MA6.68MShares$401 Million0.02% of portfolio
About EXACT SCIENCES CORP
- Ticker EXAS
- Exchange NASDAQ
- Sector Healthcare
- Industry Diagnostics & Research
- Shares Outstandng 176,960,000
- Market Cap $10.6B
- Description
- Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...